Abstract:Objective To investigate the active screening for carbapenem-resistant Enterobacteriaceae (CRE) in anal swabs of hematologic malignancy patients and factors influencing secondary bloodstream infections.Methods A total of 1,258 hematologic malignancy patients treated at the First Affiliated Hospital of Soochow University from September 2020 to June 2022 were included in this study. All patients underwent active screening for CRE using anal swabs. The study analyzed the distribution of CRE colonization, the occurrence of bloodstream infections, and associated factors.Results A total of 109 CRE strains were detected, primarily including Klebsiella pneumoniae and Escherichia coli. Ten patients developed CRE bloodstream infections. The dominant CRE enzyme types were NDM and KPC. The colonization rate of CRE in patients with neutropenia was higher than in those without neutropenia (P < 0.05). Patients with gastrointestinal symptoms had a higher CRE colonization rate compared to those without gastrointestinal symptoms (P < 0.05). Multifactorial stepwise logistic regression analysis showed that neutropenia [O^R = 2.252 (95% CI: 1.570, 3.231) ] was a significant factor associated with CRE colonization in hematologic malignancy patients (P < 0.05). No statistically significant differences were observed in the occurrence of bloodstream infections based on gender, age, disease type, presence of neutropenia, or gastrointestinal symptoms (P > 0.05).Conclusion Active screening for CRE in anal swabs of hematologic malignancy patients is an effective method to identify CRE carriers. CRE colonization is associated with neutropenia, and this should be clinically addressed.